Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.
Marcsisin SR, Sousa JC, Reichard GA, Caridha D, Zeng Q, Roncal N, McNulty R, Careagabarja J, Sciotti RJ, Bennett JW, Zottig VE, Deye G, Li Q, Read L, Hickman M, Dhammika Nanayakkara NP, Walker LA, Smith B, Melendez V, Pybus BS.
Marcsisin SR, et al. Among authors: melendez v.
Malar J. 2014 Jan 3;13:2. doi: 10.1186/1475-2875-13-2.
Malar J. 2014.
PMID: 24386891
Free PMC article.